Twinject and injection site haematoma Patient Reports February 11, 2012

Twinject Side Effects Report #5912882-2
Twinject side effect was reported by a Consumer or non-health professional from on Sept 22, 2008. Female patient, 37 years of age, weighting 190.0 lb, was diagnosed with anaphylactic reaction and was treated with Twinject. After drug was administered, patient experienced the following side effects: device malfunction, injection site haematoma, product quality issue, puncture site reaction, wound . Twinject dosage: 0.3 MG PRN SUBCUTANEOUS/INTRAMUSCULAR. During the same period patient was treated with VITAMINE D3, TOPAMAX, RITALIN, SPIRONOLACTONE, SPIRIVA, PREVACID, REACTINE, REMERON. Patient recovered.